Kidney Research and Clinical Practice

Risk of mortality and cause of death according to kidney function parameters: a nationwide observational study in Korea: Sehyun Jung, Soojin Lee, Yaerim Kim et al.; Kidney Res Clin Pract. 2024;43(2):202-215. Published online March 20, 2024; DOI: https://doi.org/10.23876/j.krcp.22.088; Full text PubReader ePub PDF Supplementary Material

Associations of metabolic variabilities and cardiovascular outcomes according to estimated glomerular filtration rate in chronic kidney disease: a nationwide observational cohort study: Jeong Min Cho, Kyungdo Han, Kwon Wook Joo et al.; Received May 24, 2023 Accepted August 16, 2023 Published online January 12, 2024; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Impact of albuminuria on early-onset type 2 diabetes mellitus: a nationwide population-based study: Soojin Lee, Semin Cho, Geum Nae Nam et al.; Received November 25, 2022 Accepted July 11, 2023 Published online December 11, 2023; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Baseline characteristics of the Korean genetic cohort of inherited cystic kidney disease: Jeong Min Cho, Hayne Cho Park, Jin Woo Lee et al.; Kidney Res Clin Pract. 2023;42(5):617-627. Published online September 27, 2023; DOI: https://doi.org/10.23876/j.krcp.23.097; Full text PubReader ePub PDF Supplementary Material

Genetic variations in HMGCR and PCSK9 and kidney function: a Mendelian randomization study: Sehoon Park, Seong Geun Kim, Soojin Lee et al.; Kidney Res Clin Pract. 2023;42(4):460-472. Published online May 22, 2023; DOI: https://doi.org/10.23876/j.krcp.22.237
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period: Hyuk Huh, Yong Soo Kim, Wookyung Chung et al.; Kidney Res Clin Pract. 2023;42(2):216-228. Published online January 13, 2023; DOI: https://doi.org/10.23876/j.krcp.22.024
Web of Science 1 Cited By 1; Full text PubReader ePub PDF Supplementary Material

Genetic variants of interferon lambda-related genes and chronic kidney disease susceptibility in the Korean population: Jin Ho Kwak, Jin Hyuk Paek, Gyeong Im Yu et al.; Kidney Res Clin Pract. 2022;41(4):442-451. Published online February 23, 2022; DOI: https://doi.org/10.23876/j.krcp.21.075
Web of Science 1 Cited By 2; Full text PubReader ePub PDF Supplementary Material

First snapshot on behavioral characteristics and related factors of patients with chronic kidney disease in South Korea during the COVID-19 pandemic (June to October 2020): Yaerim Kim, Inae Lee, Jeonghwan Lee et al.; Kidney Res Clin Pract. 2022;41(2):219-230. Published online November 9, 2021; DOI: https://doi.org/10.23876/j.krcp.21.065
Web of Science 3 Cited By 2; Full text PubReader ePub PDF Supplementary Material

Long-term risk of all-cause mortality in live kidney donors: a matched cohort study: Eunjeong Kang, Sehoon Park, Jina Park et al.; Kidney Res Clin Pract. 2022;41(1):102-113. Published online November 5, 2021; DOI: https://doi.org/10.23876/j.krcp.21.042; Full text PubReader ePub PDF Supplementary Material

Metabolic risks in living kidney donors in South Korea: Eunjeong Kang, Jina Park, Hyo Jeong Kim et al.; Kidney Res Clin Pract. 2021;40(4):645-659. Published online October 12, 2021; DOI: https://doi.org/10.23876/j.krcp.20.271
Web of Science 3 Cited By 4; Full text PubReader ePub PDF Supplementary Material

Causal effect of alcohol use on the risk of end-stage kidney disease and related comorbidities: a Mendelian randomization study: Sehoon Park, Soojin Lee, Yaerim Kim et al.; Kidney Res Clin Pract. 2021;40(2):282-293. Published online April 20, 2021; DOI: https://doi.org/10.23876/j.krcp.20.186
Web of Science 7 Cited By 7; Full text PubReader ePub PDF Supplementary Material

Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients: Woo Yeong Park, Yaerim Kim, Jin Hyuk Paek, Kyubok Jin, Seungyeup Han; Kidney Res Clin Pract. 2021;40(2):317-324. Published online April 15, 2021; DOI: https://doi.org/10.23876/j.krcp.20.183
Web of Science 7 Cited By 7; Full text PubReader ePub PDF

Reduced risk for chronic kidney disease after recovery from metabolic syndrome: A nationwide population-based study: Sehoon Park, Soojin Lee, Yaerim Kim et al.; Kidney Res Clin Pract. 2020;39(2):180-191. Published online June 30, 2020; DOI: https://doi.org/10.23876/j.krcp.20.016
Web of Science 25 Cited By 27; Full text PubReader PDF

Association of hypoalbuminemia with short-term and long-term mortality in patients undergoing continuous renal replacement therapy: Jong Joo Moon, Yaerim Kim, Dong Ki Kim, Kwon Wook Joo, Yon Su Kim, Seung Seok Han; Kidney Res Clin Pract. 2020;39(1):47-53. Published online March 31, 2020; DOI: https://doi.org/10.23876/j.krcp.19.088
Web of Science 10 Cited By 9; Full text PubReader PDF

Risk of cancer in pre-dialysis chronic kidney disease: A nationwide population-based study with a matched control group: Sehoon Park, Soojin Lee, Yaerim Kim et al.; Kidney Res Clin Pract. 2019;38(1):60-70. Published online March 31, 2019; DOI: https://doi.org/10.23876/j.krcp.18.0131
Web of Science 30 Cited By 30; Full text PubReader PDF Supplementary Material

14,682	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,687	C4d Puzzle in ABO-incompatible kidney transplantation
8,115	How should we treat acute kidney injury caused by renal congestion?
12,837	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,902	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Search